-
Practice your interview with the new SDN AI Interview Coach. Choose a school, answer by voice or typing, and receive a personalized feedback report. Available now to all SDN members. Try the AI Interview Coach.
Contrast shortage
Started by Dr. Ice
Y'all still using contrast for epidermals?Steve is drowning in Omnipaque...
I just use it for pin point injections. The patients like that term for when ortho just blindly stabs them with whatever Mississippi white bbq sauce is in the syringe.
Somehow what they do is pinpoint. And the careful things we do under Fluoro are epidermals.
Advertisement - Members don't see this ad
Boy does that epidermal work when I've stoved up my back.
You must have broken the cartridges in your back
sealed?
so were the NECC bottles. capped and sealed.
the problem was that it was from a powder and compounded under contaminated conditions. that fungus fumigated in the bottles while waiting to get used...
so were the NECC bottles. capped and sealed.
the problem was that it was from a powder and compounded under contaminated conditions. that fungus fumigated in the bottles while waiting to get used...
Any end in sight?
Anyone else dealing with the contrast shortage and looked into using Omnipaque 140 for small-volume epidural confirmation?
I went through the full PI and here's what I found — the 140 has the exact same excipients as the 180 (same tromethamine, same edetate calcium disodium, same pH, autoclaved, no preservatives). The osmolality is actually lower and closer to CSF (322 vs 408 mOsm/kg). The contraindication appears to be entirely regulatory — GE never ran intrathecal trials with the 140 since it was developed for IA-DSA. There's no toxicology or adverse event data distinguishing it from the 180.
At 0.5 cc for needle confirmation, I'm having a hard time seeing the risk. Curious what others think or if anyone's already doing this with appropriate documentation. The alternative right now is gadolinium (worse visibility, also off-label) or no contrast at all.
I went through the full PI and here's what I found — the 140 has the exact same excipients as the 180 (same tromethamine, same edetate calcium disodium, same pH, autoclaved, no preservatives). The osmolality is actually lower and closer to CSF (322 vs 408 mOsm/kg). The contraindication appears to be entirely regulatory — GE never ran intrathecal trials with the 140 since it was developed for IA-DSA. There's no toxicology or adverse event data distinguishing it from the 180.
At 0.5 cc for needle confirmation, I'm having a hard time seeing the risk. Curious what others think or if anyone's already doing this with appropriate documentation. The alternative right now is gadolinium (worse visibility, also off-label) or no contrast at all.
I got an email from my Bracco rep asking if I was part of a group buying program so they could adjust my pricing. This is after I placed an order successfully when supposedly they are not taking new customers. Is it a trap or do they genuinely want to give me a better price?
I don't know how legitimate this is, but googling around about the shortage I found this
skylinepharmaceuticals.net
Skyline Pharmaceuticals | NABP Wholesale Distributor
NABP-accredited pharmaceutical distributor licensed in all 50 states. Compliant supply chain for pharmacies and healthcare facilities.
skylinepharmaceuticals.net
GE HealthCare reassures customers its contrast supply is stable following recall
Since the COVID-induced global shortage of iodinated contrast occurred in 2022, the company has taken steps to ensure its supply chain remains resilient.
radiologybusiness.com
The shortage is related to a recall of omnipaque in bottles that were possibly contaminated
Anyone have an update on this? End date?
No bueno….. is anyone still getting shipments on “allocation” or nothing at all?
We are paying out the rear for little bottles of isovue
Advertisement - Members don't see this ad
